Ebos Group remains confident it can continue its pace of double-digit growth.
Increasing digitisation and developing technologies, such as artificial intelligence, should aid its radiology businesses in going global.
The NZ medicinal cannabis sector could be worth $2 billion by 2030, driven by the use of low dosage products, but that will require a change in the rules.
MedGreen's 'calculated risk' to continue to operate while under administration paid off with a successful sale to a buyer backed by experienced people in the cannabis sector.